Reasons to be bullishWeekly chart - Reasons to be bullish:
Crossover of 50 EMA by 21 EMA
Price is trending upwards
RSI is trending upwards
Price is now above 4.1 resistance
Can it go further? Wait and see?
Caveat: Rise is based on low volumes
0.0318USD
28.15 MUSD
187.53 MUSD
312.43 M
About Integrated Diagnostics Holdings PLC.
Sector
Industry
CEO
Hend El Sherbini
Website
Headquarters
St. Helier
Founded
2008
ISIN
JE00BLKGSR75
FIGI
BBG00PBHXGT1
Integrated Diagnostics Holdings Plc is an investment company, which engages in the healthcare field of medical diagnostics. Its primary provisions are pathology and radiology related tests. It operates through the following geographical segments: Egypt, Sudan, Jordan, and Nigeria. The company was founded in 2008 and is headquartered in St. Helier, the United Kingdom. .
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IDGXF is 0.2960 USD — it has increased by 7.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Integrated Diagnostics Holdings PLC. stocks are traded under the ticker IDGXF.
Integrated Diagnostics Holdings PLC. is going to release the next earnings report on Jun 5, 2024. Keep track of upcoming events with our Earnings Calendar.
IDGXF stock is 15.34% volatile and has beta coefficient of 0.84. Check out the list of the most volatile stocks — is Integrated Diagnostics Holdings PLC. there?
Integrated Diagnostics Holdings PLC. revenue for the last quarter amounts to 29.35 M USD despite the estimated figure of 29.83 M USD. In the next quarter revenue is expected to reach 37.78 M USD.
Yes, you can track Integrated Diagnostics Holdings PLC. financials in yearly and quarterly reports right on TradingView.
IDGXF net income for the last quarter is 5.75 M USD, while the quarter before that showed 1.64 M USD of net income which accounts for 250.83% change. Track more Integrated Diagnostics Holdings PLC. financial stats to get the full picture.
Today Integrated Diagnostics Holdings PLC. has the market capitalization of 208.50 M, it has increased by 8.20% over the last week.
Integrated Diagnostics Holdings PLC. dividend yield was 0% in 2022, and payout ratio reached 0%. The year before the numbers were 9.00% and 77.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, IDGXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Integrated Diagnostics Holdings PLC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Integrated Diagnostics Holdings PLC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Integrated Diagnostics Holdings PLC. stock shows the sell signal. See more of Integrated Diagnostics Holdings PLC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Integrated Diagnostics Holdings PLC. future price: according to them, IDGXF price has a max estimate of 0.67 USD and a min estimate of 0.46 USD. Read a more detailed Integrated Diagnostics Holdings PLC. forecast: see what analysts think of Integrated Diagnostics Holdings PLC. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Integrated Diagnostics Holdings PLC. EBITDA is 35.23 M USD, and current EBITDA margin is 31.56%. See more stats in Integrated Diagnostics Holdings PLC. financial statements.